Cargando…

A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice

Detalles Bibliográficos
Autores principales:	Niu, Peihua, Zhao, Guangyu, Deng, Yao, Sun, Shihui, Wang, Wenling, Zhou, Yusen, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089443/ https://www.ncbi.nlm.nih.gov/pubmed/30091015 http://dx.doi.org/10.1007/s11427-018-9343-8

Ejemplares similares

Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
por: de Wit, Emmie, et al.
Publicado: (2018)

Human neutralizing mAbs against Middle East respiratory syndrome coronavirus (MERS-CoV)
Publicado: (2014)

Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
por: He, Lei, et al.
Publicado: (2019)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
por: Yu, Xiaojuan, et al.
Publicado: (2015)

Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China
por: Wang, Wenling, et al.
Publicado: (2016)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

MERS
por: Memish, Z.
Publicado: (2016)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

A novel luciferase immunosorbent assay performs better than a commercial enzyme-linked immunosorbent assay to detect MERS-CoV specific IgG in humans and animals
por: Wang, Wenling, et al.
Publicado: (2019)

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2018)

Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2
por: Larrosa, Cristina, et al.
Publicado: (2023)

Host susceptibility to MERS-CoV infection, a retrospective cohort study of the 2015 Korean MERS outbreak
por: Ko, Jae-Hoon, et al.
Publicado: (2018)

La mer /
por: Michelet, Jules, 1798-1874
Publicado: (1869)

MERS-COV
por: Memish, Z.
Publicado: (2014)

MERS in pregnancy
por: Joob, Beuy, et al.
Publicado: (2016)

Update MERS
por: Prange-Schmidt, Susanne
Publicado: (2015)

Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from the First Imported MERS-CoV Case in China
por: Lu, Roujian, et al.
Publicado: (2015)

Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus
por: Tian, Puyuan, et al.
Publicado: (2019)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
por: Ma, Cuiqing, et al.
Publicado: (2014)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2016)

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2013)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

A lesson learned from the MERS epidemic in Korea: an essay on MERS
por: Meng, Kwang-Ho
Publicado: (2015)

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017)

Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2022)

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019)

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
por: Tang, Jian, et al.
Publicado: (2015)

La Mer promise /
por: Perrin, Joseph, 1917-
Publicado: (1971)

La mer ; Ibéria
por: Debussy, Claude, 1862-1918
Publicado: (1997)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Cardiac problem and MERS
por: Wiwanitkit, Viroj
Publicado: (2015)

Is MERS another SARS?
por: Drosten, Christian
Publicado: (2013)

MERS—an uncertain future
por: The Lancet Infectious Diseases
Publicado: (2015)

Pilgrims warned of MERS
Publicado: (2015)

Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2019)

Identification of Lysine Acetylation Sites on MERS-CoV Replicase pp1ab
por: Zhu, Lin, et al.
Publicado: (2020)

Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
por: Qiu, Hongjie, et al.
Publicado: (2016)

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
por: Zhou, Yusen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fpvvc7gb39tqogh3d50d5sc1sv